Literature DB >> 9329384

Endothelin-1 stimulates steroid secretion of human adrenocortical cells ex vivo via both ETA and ETB receptor subtypes.

G P Rossi1, G Albertin, G Neri, P G Andreis, S Hofmann, A C Pessina, G G Nussdorfer.   

Abstract

The role played by endothelins (ETs) and their receptor subtypes (ETA and ETB) in the regulation of steroid hormone secretion in human adrenal gland remains unclear. Therefore, we investigated the gene expression of ET-1 and its receptors in highly pure preparations of human adrenocortical cells and the effect of ET-1 on their secretory activity. Reverse transcription-PCR with primers specific for prepro-ET-1, ET-converting enzyme-1, ETA, and ETB complementary DNAs demonstrated the expression of all of these genes in human adrenocortical cells. ET-1 increased the secretion of aldosterone and cortisol by enhancing both earlier and late steps of their synthesis. The secretory response to ET-1 was partially (60%) inhibited by BQ-123 and BQ-788, which are selective antagonists of the ETA and ETB receptors, respectively. When added together, the two antagonists suppressed the secretagogue effect of ET-1. Collectively, these findings suggest that ET-1, acting via both ETA and ETB receptors, may exert an autocrine/paracrine regulation of the function of the human adrenal cortex.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9329384     DOI: 10.1210/jcem.82.10.4279

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

Review 1.  Regulation of blood pressure and salt homeostasis by endothelin.

Authors:  Donald E Kohan; Noreen F Rossi; Edward W Inscho; David M Pollock
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

2.  Plasma aldosterone and its relationship with left ventricular mass in hypertensive patients with early-stage chronic kidney disease.

Authors:  Giuseppe Mulè; Emilio Nardi; Laura Guarino; Valentina Cacciatore; Giulio Geraci; Ilenia Calcaterra; Bruno Oddo; Francesco Vaccaro; Santina Cottone
Journal:  Hypertens Res       Date:  2015-01-08       Impact factor: 3.872

3.  Aldosterone inactivates the endothelin-B receptor via a cysteinyl thiol redox switch to decrease pulmonary endothelial nitric oxide levels and modulate pulmonary arterial hypertension.

Authors:  Bradley A Maron; Ying-Yi Zhang; Kevin White; Stephen Y Chan; Diane E Handy; Christopher E Mahoney; Joseph Loscalzo; Jane A Leopold
Journal:  Circulation       Date:  2012-07-11       Impact factor: 29.690

4.  Impact of mineralocorticoid receptor blockade with direct renin inhibition in angiotensin II-dependent hypertensive mice.

Authors:  Atsushi Hashimoto; Yoshimichi Takeda; Shigehiro Karashima; Mitsuhiro Kometani; Daisuke Aono; Masashi Demura; Takuya Higashitani; Seigo Konishi; Takashi Yoneda; Yoshiyu Takeda
Journal:  Hypertens Res       Date:  2020-05-12       Impact factor: 3.872

Review 5.  The Biology of Normal Zona Glomerulosa and Aldosterone-Producing Adenoma: Pathological Implications.

Authors:  Teresa M Seccia; Brasilina Caroccia; Elise P Gomez-Sanchez; Celso E Gomez-Sanchez; Gian Paolo Rossi
Journal:  Endocr Rev       Date:  2018-12-01       Impact factor: 19.871

6.  Plasma aldosterone levels are elevated in patients with pulmonary arterial hypertension in the absence of left ventricular heart failure: a pilot study.

Authors:  Bradley A Maron; Alexander R Opotowsky; Michael J Landzberg; Joseph Loscalzo; Aaron B Waxman; Jane A Leopold
Journal:  Eur J Heart Fail       Date:  2012-10-30       Impact factor: 15.534

Review 7.  Aldosterone affects blood flow and vascular tone regulated by endothelium-derived NO: therapeutic implications.

Authors:  Noboru Toda; Sadanobu Nakanishi; Shinichi Tanabe
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

8.  Mineralocorticoid receptor antagonist treatment of established pulmonary arterial hypertension improves interventricular dependence in the SU5416-hypoxia rat model.

Authors:  Mengyun Lu; Li-Yuan Chen; Salina Gairhe; Adrien J Mazer; Stasia A Anderson; Jasmine N H Nelson; Audrey Noguchi; Mohammad Abdul Hai Siddique; Edward J Dougherty; Yvette Zou; Kathryn A Johnston; Zu-Xi Yu; Honghui Wang; Shuibang Wang; Junfeng Sun; Steven B Solomon; Rebecca R Vanderpool; Michael A Solomon; Robert L Danner; Jason M Elinoff
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2022-01-19       Impact factor: 5.464

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.